Review paper
Reductions in albuminuria with SGLT2 inhibitors: a marker for improved renal outcomes in patients without diabetes?
Abstract
Very high albuminuria (>300 mg per day) is a clear indicator of kidney disease and its reduction is considered the hallmark of long-term slowing of chronic kidney disease progression. A sustained 30% reduction in albuminuria over a year or longer has been associated with slowed nephropathy progression and is considered a marker of renal benefit. 1 Coresh J Heerspink HJL Sang Y et al. Change in albuminuria and subsequent risk of end-stage kidney...
Paper Details
Title
Reductions in albuminuria with SGLT2 inhibitors: a marker for improved renal outcomes in patients without diabetes?
Published Date
Jul 1, 2020
Volume
8
Issue
7
Pages
553 - 555
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History